Skip to main content

Animations

MJFF Publications

6311 - 6320 of 8819 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2020
  • 2021
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab073
    Citation Count: 26
  • Summary Details
    OPEN
    Title: NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab214
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Deep Brain Stimulation of the Subthalamic, Accumbens, or Caudate Nuclei for Patients With Severe Obsessive-Compulsive Disorder: A Randomized Crossover Controlled Study
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.07.013
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Transcriptome-wide Association Study in Frontotemporal Dementia Identifies New Disease Loci by In Silico Analysis
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.02.010
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.